Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine femoral block versus intrathecal morphine after total hip replacement
NL-OMON31034Phase 4Withdrawn
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine, morphine and bupivacaine in postoperative pain (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoints: Pain scores, Itching and 3 more. Planned start Dec 2008; status: withdrawn.
02
Drugs
ropivacainemorphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON31034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31034.